Latest Articles
Identification of key genes associated with infertile endometriosis based on bioinformatic analysis - Frontiers
Identification of key genes associated with infertile endometriosis based on bioinformatic analysis Frontiers
Published: July 2, 2025, 4:08 p.m.
Organon's non-hormonal endometriosis hope dashed - FirstWord Pharma
Organon's non-hormonal endometriosis hope dashed FirstWord Pharma
Published: July 2, 2025, 3:25 p.m.
Organon stops work on drug once viewed as ‘game-changing’; NextPoint culls an asset - Endpoints News
Organon stops work on drug once viewed as ‘game-changing’; NextPoint culls an asset Endpoints News
Published: July 2, 2025, 2:34 p.m.
Women with endometriosis-associated infertility are more likely to become pregnant, study reveals - News-Medical
Women with endometriosis-associated infertility are more likely to become pregnant, study reveals News-Medical
Published: July 2, 2025, 1:30 p.m.
Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain - MarketScreener
Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain MarketScreener
Published: July 2, 2025, 12:51 p.m.
Organon axes 'biggest potential opportunity' after flunking phase 2 trial - Fierce Biotech
Organon axes 'biggest potential opportunity' after flunking phase 2 trial Fierce Biotech
Published: July 2, 2025, 12:43 p.m.
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued - Stock Titan
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued Stock Titan
Published: July 2, 2025, 11:30 a.m.
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country - Express Pharma
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country Express Pharma
Published: July 2, 2025, 7 a.m.
AstraZeneca Pharma India gets CDSCO nod for expanded use of Imfinzi in Endometrial Cancer - Medical Dialogues
AstraZeneca Pharma India gets CDSCO nod for expanded use of Imfinzi in Endometrial Cancer Medical Dialogues
Published: July 2, 2025, 6:31 a.m.
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion - Nature
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion Nature
Published: July 2, 2025, 5:48 a.m.
Link copied to clipboard!